Cite

HARVARD Citation

    Kim, W. et al. (n.d.). AN ONGOING PHASE 1/1B TRIAL INVESTIGATING NOVEL TREATMENT REGIMENS WITH MOSUNETUZUMAB IN RELAPSED/REFRACTORY B‐CELL NON‐HODGKIN LYMPHOMA. Hematological oncology. pp. 567-568. [Online]. 
  
Back to record